Speaking of Xalkori…PFE’s head of oncology and specialty pharma, Gene Germano, is presenting at the Cowen conference on 3/6/12 at 10am. Ought to be some discussion of Inlyta and possibly Bosutinib.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”